“…The advantages of antibody detection systems include high sensitivity, relatively straightforward automation, and large scale processing of samples (Doenhoff et al, 2004;Weerakoon et al, 2015). However, these systems also have several limitations: i) antibodies may circulate for a long time after an infection is cured (Capron et al, 1969;Tosswill and Ridley, 1986); ii) cross-reactivity between antigens from Schistosoma species and other helminths may occur (Alarcón- de-Noya et al, 1996); iii) difficulties with large scale production may be encountered; iv) some techniques have significant costs and require complex equipment; v) there are operational complexities associated with blood collection and the transportation and storage of sera; and vi) there may be difficulties in evaluating performance (Doenhoff et al, 2004;Hamilton et al, 1998). Lack of reproducibility between different batches of reagents may further hinder or delay implementation of new diagnostics (Banoo et al, 2006).…”